These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 16837633)

  • 21. Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels.
    Roy P; Raya V; Okabe T; Pinto Slottow TL; Steinberg DH; Smith K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2008 Jun; 101(11):1544-9. PubMed ID: 18489931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between operator volume and adverse outcome in contemporary percutaneous coronary intervention practice: an analysis of a quality-controlled multicenter percutaneous coronary intervention clinical database.
    Moscucci M; Share D; Smith D; O'Donnell MJ; Riba A; McNamara R; Lalonde T; Defranco AC; Patel K; Kline Rogers E; D'Haem C; Karve M; Eagle KA
    J Am Coll Cardiol; 2005 Aug; 46(4):625-32. PubMed ID: 16098426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical judgment and treatment options in stable multivessel coronary artery disease: results from the one-year follow-up of the MASS II (Medicine, Angioplasty, or Surgery Study II).
    Pereira AC; Lopes NH; Soares PR; Krieger JE; de Oliveira SA; Cesar LA; Ramires JA; Hueb W
    J Am Coll Cardiol; 2006 Sep; 48(5):948-53. PubMed ID: 16949484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and prognostic implications of ST-segment deviations from ambulatory Holter monitoring after ST-segment elevation myocardial infarction treated with either fibrinolysis or primary percutaneous coronary intervention (a Danish Trial in Acute Myocardial Infarction-2 Substudy).
    Idorn L; Høfsten DE; Wachtell K; Mølgaard H; Egstrup K;
    Am J Cardiol; 2007 Sep; 100(6):937-43. PubMed ID: 17826373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Culprit only versus complete coronary revascularization during primary PCI.
    Qarawani D; Nahir M; Abboud M; Hazanov Y; Hasin Y
    Int J Cardiol; 2008 Jan; 123(3):288-92. PubMed ID: 17428557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of interventionalist volume, experience, and board certification on coronary angioplasty outcomes in the era of stenting.
    Harjai KJ; Berman AD; Grines CL; Kahn J; Marsalese D; Mehta RH; Schreiber T; Boura JA; O'Neill WW
    Am J Cardiol; 2004 Aug; 94(4):421-6. PubMed ID: 15325922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse clinical events in patients treated with sirolimus-eluting stents: the impact of Type D personality.
    Pedersen SS; Denollet J; Ong AT; Sonnenschein K; Erdman RA; Serruys PW; van Domburg RT
    Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):135-40. PubMed ID: 17301639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.
    Anselmino M; Malmberg K; Ohrvik J; Rydén L;
    Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):216-23. PubMed ID: 18391651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognosis of asymptomatic coronary artery disease after percutaneous coronary intervention.
    Wakabayashi K; Delhaye C; Maluenda G; Ben-Dor I; Gonzalez MA; Collins SD; Syed AI; Gaglia MA; Torguson R; Xue Z; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
    Am J Cardiol; 2010 Jun; 105(11):1507-12. PubMed ID: 20494653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events.
    Marcucci R; Paniccia R; Antonucci E; Gori AM; Fedi S; Giglioli C; Valente S; Prisco D; Abbate R; Gensini GF
    Am J Cardiol; 2006 Nov; 98(9):1156-9. PubMed ID: 17056317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stents.
    Shaw JA; Andrianopoulos N; Duffy S; Walton AS; Clark D; Lew R; Sebastian M; New G; Brennan A; Reid C; Ajani AE;
    Cardiovasc Revasc Med; 2008; 9(4):218-23. PubMed ID: 18928945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An evaluation of octogenarians undergoing percutaneous coronary intervention from the Melbourne Interventional Group registry.
    Yan BP; Gurvitch R; Duffy SJ; Clark DJ; Sebastian M; New G; Warren R; Lefkovits J; Lew R; Brennan AL; Reid C; Andrianopoulos N; Ajani AE
    Catheter Cardiovasc Interv; 2007 Dec; 70(7):928-36. PubMed ID: 18044763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
    Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H
    J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early invasive treatment benefits patients with renal dysfunction in unstable coronary artery disease.
    Johnston N; Jernberg T; Lagerqvist B; Wallentin L
    Am Heart J; 2006 Dec; 152(6):1052-8. PubMed ID: 17161052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization.
    Buszman PE; Kiesz SR; Bochenek A; Peszek-Przybyla E; Szkrobka I; Debinski M; Bialkowska B; Dudek D; Gruszka A; Zurakowski A; Milewski K; Wilczynski M; Rzeszutko L; Buszman P; Szymszal J; Martin JL; Tendera M
    J Am Coll Cardiol; 2008 Feb; 51(5):538-45. PubMed ID: 18237682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three-year survival after percutaneous coronary intervention according to appropriateness criteria for revascularization.
    Brener SJ; Haq SA; Bose S; Sacchi TJ
    J Invasive Cardiol; 2009 Nov; 21(11):554-7. PubMed ID: 19901407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents.
    Tamburino C; Angiolillo DJ; Capranzano P; Dimopoulos K; La Manna A; Barbagallo R; Tagliareni F; Mangiafico S; Guzman LA; Galassi AR; Bass TA
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):448-56. PubMed ID: 18814218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness and cost-effectiveness of facilitated percutaneous coronary intervention compared with primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction transferred from community hospitals.
    Coleman CI; McKay RG; Boden WE; Mather JF; White CM
    Clin Ther; 2006 Jul; 28(7):1054-62. PubMed ID: 16990084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous angioplasty of chronically occluded coronary arteries: long-term clinical follow-up.
    Drozd J; Wójcik J; Opalińska E; Zapolski T; Widomska-Czekajska T
    Kardiol Pol; 2006 Jul; 64(7):667-73; discussion 674. PubMed ID: 16886123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sirolimus-eluting stent treatment at high-volume centers confers lower mortality at 6-month follow-up: results from the prospective multicenter German Cypher Registry.
    Khattab AA; Hamm CW; Senges J; Toelg R; Geist V; Bonzel T; Kelm M; Levenson B; Nienaber CA; Pfannebecker T; Sabin G; Schneider S; Tebbe U; Neumann FJ; Richardt G;
    Circulation; 2009 Aug; 120(7):600-6. PubMed ID: 19652087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.